Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
NCT ID: NCT00099242
Last Updated: 2017-10-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
1040 participants
INTERVENTIONAL
2003-11-30
2006-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rivastigmine transdermal patch
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Males, and females who are surgically sterile or one year postmenopausal
* A primary caregiver willing to accept responsibility for supervising the treatment
Exclusion Criteria
* An advanced, severe or unstable disease that may put the patient at special risk
* Current diagnosis of active, uncontrolled seizure disorder or unstable cardiovascular disease
50 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novartis Pharmaceuticals
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Orange, California, United States
San Francisco, California, United States
Boca Raton, Florida, United States
Fort Lauderdale, Florida, United States
Miami, Florida, United States
Miami Beach, Florida, United States
Port Charlotte, Florida, United States
West Palm Beach, Florida, United States
Snellville, Georgia, United States
St Louis, Missouri, United States
Omaha, Nebraska, United States
Long Branch, New Jersey, United States
Toms River, New Jersey, United States
Whiting, New Jersey, United States
Columbus, Ohio, United States
Dayton, Ohio, United States
Oklahoma City, Oklahoma, United States
Greensburg, Pennsylvania, United States
Nashville, Tennessee, United States
Austin, Texas, United States
Houston, Texas, United States
Tacoma, Washington, United States
Santiago, , Chile
Valparaíso, , Chile
Brno, , Czechia
Brno-Bohunice, , Czechia
Hradec Králové, , Czechia
Olomouc, , Czechia
Prague, , Czechia
Copenhagen, , Denmark
Glostrup Municipality, , Denmark
Hillerød, , Denmark
Kuopio, , Finland
Investigative Sites, , Germany
Guatemala City, , Guatemala
Beersheva, , Israel
Haifa, , Israel
Jerusalem, , Israel
Petah Tikva, , Israel
Tel Aviv, , Israel
Lido di Camaiore, , Italy
Milan, , Italy
Pescara, , Italy
Guadalajara Jalisco, , Mexico
Mexico City, , Mexico
Monterrey Nuevo Leon, , Mexico
Bodø, , Norway
Oslo, , Norway
Tromsø, , Norway
Trondheim, , Norway
Lima, , Peru
Gdansk, , Poland
Lublin, , Poland
Poznan, , Poland
Szczecin, , Poland
Warsaw, , Poland
Amadora, , Portugal
Coimbra, , Portugal
Bayamón, , Puerto Rico
Moscow, , Russia
Saint Petersburg, , Russia
Bratislava, , Slovakia
Michalovce, , Slovakia
Jungbuk, , South Korea
KyungKi-province, , South Korea
Seoul, , South Korea
Gothenburg, , Sweden
Kalmar, , Sweden
Stockholm, , Sweden
Uppsala, , Sweden
Kaohsiung City, , Taiwan
Taichung, , Taiwan
Taipei, , Taiwan
Taoyuan District, , Taiwan
Ciudad Merida, Mérida, Venezuela
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lefevre G, Callegari F, Gsteiger S, Xiong Y. Effects of Renal Impairment on Steady-State Plasma Concentrations of Rivastigmine: A Population Pharmacokinetic Analysis of Capsule and Patch Formulations in Patients with Alzheimer's Disease. Drugs Aging. 2016 Oct;33(10):725-736. doi: 10.1007/s40266-016-0405-y.
Alva G, Grossberg GT, Schmitt FA, Meng X, Olin JT. Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analyses. Int J Geriatr Psychiatry. 2011 Apr;26(4):356-63. doi: 10.1002/gps.2534.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CENA713D2320
Identifier Type: -
Identifier Source: org_study_id